Seminars in Thoracic and Cardiovascular Surgery
Volume 19, Issue 2 , Pages 151-156 , Summer 2007

Optimizing the Selection of Surgical Candidates for Lung Volume Reduction Surgery

  • Steven J. Mentzer, MD

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Steven J. Mentzer, MD, Room 259, Division of Thoracic Surgery, Brigham and Women’s Hospital, 75 Francis St, Boston, MA 02115.

References 

  1. Fishman A, Martinez F, Naunheim K, et al. A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. N Engl J Med. 2003;348:2059–2073
  2. Rationale and design of the National Emphysema Treatment Trial (NETT). A prospective randomized trial of lung volume reduction surgery. J Thorac Cardiovasc Surg. 1999;118:518–528
  3. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (American Thoracic Society). Am J Respir Crit Care Med. 1995;152:S77–S121
  4. Pauwels RA, Buist AS, Calverley PM, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease (NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary). Am J Respir Crit Care Med. 2001;163:1256–1276
  5. Kerstjens HA. The GOLD classification has not advanced understanding of COPD. Am J Respir Crit Care Med. 2004;170:212–213discussion 214
  6. Hajiro T, Nishimura K, Tsukino M, et al. A comparison of the level of dyspnea vs disease severity in indicating the health-related quality of life of patients with COPD. Chest. 1999;116:1632–1637
  7. Kaplan RM, Ries AL, Reilly J, et al. Measurement of health-related quality of life in the national emphysema treatment trial. Chest. 2004;126:781–789
  8. Brantigan OC, Mueller E, Kress MB. A surgical approach to pulmonary emphysema. Am Rev Respir Dis. 1959;80:194–206
  9. Ware JH. The National Emphysema Treatment Trial—how strong is the evidence?. N Engl J Med. 2003;348:2055–2056
  10. Ingenito EP, Evans RB, Loring SH, et al. Relation between preoperative inspiratory lung resistance and the outcome of lung-volume-reduction surgery for emphysema. N Engl J Med. 1998;338:1181–1185
  11. Ingenito EP, Loring SH, Moy ML, et al. Physiological characterization of variability in response to lung volume reduction surgery. J Appl Physiol. 2003;94:20–30
  12. National Emphysema Treatment Trial Research Group. Patients at high risk of death after lung-volume-reduction surgery. N Engl J Med. 2001;345:1075–1083
  13. Naunheim KS, Wood DE, Krasna MJ, et al. Predictors of operative mortality and cardiopulmonary morbidity in the National Emphysema Treatment Trial. J Thorac Cardiovasc Surg. 2006;131:43–53
  14. DeCamp MM, Blackstone EH, Naunheim KS, et al. Patient and surgical factors influencing air leak after lung volume reduction surgery: lessons learned from the National Emphysema Treatment Trial. Ann Thorac Surg. 2006;82:197–206discussion 206-197
  15. Thurnheer R, Muntwyler J, Stammberger U, et al. Coronary artery disease in patients undergoing lung volume reduction surgery for emphysema. Chest. 1997;112:122–128
  16. Gianrossi R, Detrano R, Colombo A, et al. Cardiac fluoroscopy for the diagnosis of coronary artery disease: a meta analytic review. Am Heart J. 1990;120:1179–1188
  17. Ritchie J, Bateman T, Bonow R, et al. ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (ACC/AHA/ASNC Committee to revise the 1995 guidelines). Bethesda, MD: American College of Cardiology Foundation 69; 2003;
  18. Weg IL, Rossoff L, McKeon K, et al. Development of pulmonary hypertension after lung volume reduction surgery. Am J Respir Crit Care Med. 1999;159:552–556
  19. Chemla D, Castelain V, Herve P, et al. Haemodynamic evaluation of pulmonary hypertension. Eur Respir J. 2002;20:1314–1331
  20. Ries AL, Make BJ, Lee SM, et al. The effects of pulmonary rehabilitation in the national emphysema treatment trial. Chest. 2005;128:3799–3809
  21. California Pulmonary Rehabilitation Collaborative Group. Effects of pulmonary rehabilitation on dyspnea, quality of life, and healthcare costs in California. J Cardiopulmonary Rehab. 2004;24:52–62
  22. Beck AT, Ward CH, Mendelson M, et al. An inventory for measuring depression. Arch Gen Psychiatry. 1961;4:561–571
  23. Reitan R. Validity of the trail making test as an indicator of organic brain damage. Precept Mot Skills. 1958;8:271–276

PII: S1043-0679(07)00086-X

doi: 10.1053/j.semtcvs.2007.05.006

Seminars in Thoracic and Cardiovascular Surgery
Volume 19, Issue 2 , Pages 151-156 , Summer 2007

Article Tools